Status:
RECRUITING
Dexamethasone and Pregnancy: Maternal Effects
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Dexamethasone During Pregnancy
Eligibility:
FEMALE
18+ years
Brief Summary
This study will analyze obstetric, endocrine and metabolic follow-up data in women treated with DEX. It will reveal the prevalence and importance of weight gain, insomnia, edema, stretch marks, arteri...
Detailed Description
Main objective: The main aim of this study was to assess the incidence of metabolic complications (hypertension and diabetes) in mothers treated with DEX during pregnancy. Secondary objectives: 1. ...
Eligibility Criteria
Inclusion Criteria:
-
Femme majeure (âge ≥ 18 ans)
-
Grossesse avec indication de traitement anténatal par dexaméthasone (DEX) en accord avec le PNDS :
- Mutation sévère du gène CYP21A2 chez chacun des parents
- Fœtus féminin
-
Grossesse unique
-
Ayant commencé un traitement anténatal par DEX depuis au moins 24h
Exclusion Criteria:
- Contraindication to dexamethasone treatment
- Objection to use of data
- Persons under legal protection (curatorship, guardianship), court-appointed guardians
Key Trial Info
Start Date :
September 30 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2028
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT06259994
Start Date
September 30 2024
End Date
December 30 2028
Last Update
December 17 2024
Active Locations (17)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Haut Leveque - Endocrinologie
Bordeaux, France
2
Endocrinologie - Hospices civils de Lyon
Bron, France, 69500
3
Hospices civils de Lyon Biochimie et Biologie moléculaire UM Pathologies endocriniennes
Bron, France, 69500
4
Hospices civils de Lyon Laboratoire de Biologie Médicale Multi Sites
Bron, France, 69500